Abstract
Introduction
Uterine leiomyoma is the most common benign smooth muscle tumor.
Objective
This study was carried out to evaluate the association of ER-α, CYP1A1, and CYP1B1 polymorphisms with uterine leiomyoma in Egyptian women.
Methods
The study population consisted of 160 patients with uterine leiomyoma and 100 healthy women as control. The genetic polymorphisms for ER-α MSP1 exon 1, CYP1B1 Leu432Val, and CYP1A1 Ile462Val were analyzed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) and DNA sequencing methods.
Results
There were no statistically significant differences in the overall associations between the ER-α exon I CT genotypes and uterine leiomyoma (P = 0.47). However, an elevated risk of uterine leiomyoma was observed among women with the CYP1A1 Ile462Val AG genotype (P = 0.07) and CYP1B1 Leu 432Val C/C genotype (P = 0.08).
Conclusion
We concluded that the carriage of CYP1A1 Ile462Val AG and CYP1B1 Leu 432Val CC genotypes predict the susceptibility to leiomyoma in Egyptian women and they are likely to contribute in the pathogenesis of leiomyoma.
Similar content being viewed by others
References
Parker WH (2007) Etiology, symptomatology and diagnosis of uterine myomas. Fertil Steril 87:725–736
Haney AF (2000) Clinical decision making regarding leiomyomata: what we need in the next millennium. Environ Health Perspect 108(Suppl 5):835–839
Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188:100–107
Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J, Gilbert M, Hamann U, Scott RJ (2010) Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk. Cancer Epidemiol [Epub ahead of print]
Jakimiuk AJ, Bogusiewiez M, Tarkowski R, Dziduch P et al (2004) Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women. Fertil Steril 82:1244–1249
Shastry BS (2002) SNP alleles in human disease and evolution. J Hum Genet 47(11):561–566
Ye Yi, Cheng Xiao, Hai-Boluo Li, Liu Ying-Bi, Li Yi-Ping (2008) CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Genet 25:389–394
Zhou XJ, Cen XJ, Lu DR (2004) Distribution of the CYP1A1 polymorphisms in shanghai population. J Kunming Teach Coll 26:53–58
Aklillu E, Dverbo S, Botnen IV, Otter C, Ingelman-Sundberg M (2005) Characterization of common CYP1B1 variants with different capacity for benzo(a)pyrene-7,8-dihydrodiol epoxide formation from benzo(a)pyrene. Cancer Res 65:5105–5111
Dupont W, Plummer W (1997) PS power and sample size program available for free on the internet. Control Clin Trials 18:274
Massart F, Becherinil L, Marini F et al (2003) Analysis of estrogen receptor (ERα and ERβ) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Med Sci Monit 9(1):25–30
Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT (1995) 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 92:9220–9224
Zhai X-D, Ye Y, Yang Y, Wang Z, Mo Y-N (2009) No association between estrogen receptor beta polymorphisms and uterine leiomyoma. DNA Cell Biol 28(12):633–636
Hsieh YY, Wang YK, Chang CC, Lin CS (2007) Estrogen receptor (alpha)-351 x bal* G and -397 Pvull, *C-related genotypes and alleles are associated with higher susceptibilities of endometriosis and leiomyoma. Mol Hum Reprod 13(2):117–122
Newbold RR, Liehr JG (2000) Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 60:235–237
Herr S, Bettenorf H, Denschlag D, Keck C, Pietrowski D (2006) Cytochrome P2A13 and P1A1 gene polymorphism are associated with the occurence of uterine leiomyoma. Arch Gynecol Obstet 247:0201–0208
Boyapati SM, Shu XO, Gao YT, Cai Q, Jin F, Zheng W (2005) Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case control study of Chinese women. Cancer 103:2228–2235
Sillanpaa P, Heikinheimo L, Kataja V, Eskelinen L et al (2007) CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish Caucasian population. Breast Cancer Res Treat 104:287–297
Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T (1986) The molecular mechanisms of two common polymorphisms of drug oxidation*/evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica 16:449–464
Gaudet MM, Chanoch S, Lissowska J, Berndt SI, Yang XR, Peplonska B et al (2006) Genetic variation of cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among polish women. Pharmacogenet Genomics 16:547–553
Paracchini V, Raimondi S, Gram LI, Kang D, Cocabas NA, Kristensen NV et al (2007) Meta-and pooled analyses of the cytochrome P-450 1B1val 432 leu polymorphism and breast cancer: a HuGE-GSEC review. Am J Epidemiol 165:115–125
Cho YJ, Hur SE, Lee JY, Song IO, Moon HS, Koong MK et al (2007) Single nucleotide polymorphisms and haplotypes of the genes encoding the CYP1B1 in Korean women: no association with advanced endometriosis. J Assist Reprod Genet 24:271–277
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
El-Shennawy, G.A., Elbialy, AA.A., Isamil, A.E. et al. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?. Arch Gynecol Obstet 283, 1313–1318 (2011). https://doi.org/10.1007/s00404-010-1550-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1550-x